LI Mei, LI Wenbo. Effect of Shengmai Powder Decoction in the treatment of patients with type 2 diabetes mellitus differentiated as syndrome of Qi and Yin deficiency combined with angina pectoris of coronary heart disease[J]. Journal of Clinical Medicine in Practice, 2020, 24(12): 77-79. DOI: 10.7619/jcmp.202012022
Citation: LI Mei, LI Wenbo. Effect of Shengmai Powder Decoction in the treatment of patients with type 2 diabetes mellitus differentiated as syndrome of Qi and Yin deficiency combined with angina pectoris of coronary heart disease[J]. Journal of Clinical Medicine in Practice, 2020, 24(12): 77-79. DOI: 10.7619/jcmp.202012022

Effect of Shengmai Powder Decoction in the treatment of patients with type 2 diabetes mellitus differentiated as syndrome of Qi and Yin deficiency combined with angina pectoris of coronary heart disease

More Information
  • Received Date: March 24, 2020
  • Objective To investigate the effect of Shengmai Powder Decoction in the treatment of patients with type 2 diabetes mellitus(T2DM)differentiated as syndrome of Qi and Yin deficiency combined with angina pectoris of coronary heart disease. Methods Totally 80 patients with T2DM differentiated as syndrome of Qi and Yin deficiency combined with angina pectoris of coronary heart disease were randomly divided into two groups, with 40 cases in each group. The control group was treated with western medicine, and the study group was treated with Shengmai Powder Decoction. The levels of serum homocysteine(Hcy)and C reactive protein(CRP), blood glucose indexes [fasting blood glucose(FPG), glycosylated hemoglobin(HbA1c), fasting insulin(FINS), and insulin resistance index(HOMA-IR)], frequency of angina pectoris, duration of each attack and electrocardiogram efficacy were compared before and after treatment between the two groups. Results After treatment, the levels of Hcy and CRP were significantly lower than those before treatment in both groups, and the study group was significantly lower than the control group(P<0.05). After treatment, the levels of FPG, HbA1c, FINS and HOMA-IR were significantly lower than those before treatment in both groups, and the study group was significantly lower than the control group(P<0.05). After treatment, the frequency of angina pectoris and duration of each attack in both groups were significantly less or shorter than those before treatment, and the study group was significantly better than the control group(P<0.05). The total effective rate in the study group was 95.00%, which was - significantly higher than 77.50% in the control group(P<0.05). Conclusion Shengmai Powder Decoction is safe and effective in the treatment of patients with T2DM differentiated as syndrome of Qi and Yin deficiency combined with angina pectoris of coronary heart disease, which can relieve the degree of inflammatory reactions, control blood glucose level, alleviate angina symptoms, and improve prognosis.
  • 吴小慧, 刘菲, 段忠心. 生脉散对2型糖尿病大鼠炎症因子及胰岛素抵抗的影响[J]. 中国动脉硬化杂志, 2018, 26(9): 895-899.
    畅辉, 岳黎明. 中西药物联用治疗气阴两虚型冠心病心绞痛75例[J]. 西部中医药, 2019, 32(8): 98-100.
    李静, 宋莉丽. 中西医结合治疗糖尿病合并冠心病心绞痛的临床观察[J]. 中华中医药学刊, 2019, 37(2): 505-508.
    中华医学会糖尿病学分会. 中国2型糖尿病防治指南(2017年版)[J]. 中国实用内科杂志, 2018, 38(4): 292-344.
    中国心血管病预防指南(2017)写作组, 中华心血管病杂志编辑委员会. 中国心血管病预防指南(2017)[J]. 中华心血管病杂志, 2018, 46(1): 10-25.
    国家药品监督管理局. 中药新药临床研究指导原则[M]. 北京: 中国医药科技出版社, 2002: 84-85.
    唐宏霞, 董陆玲, 王新婷, 等. 益心舒胶囊治疗2型糖尿病合并冠心病心绞痛的临床疗效分析[J]. 世界中医药, 2017, 12(8): 1804-1807.
    王阶, 何庆勇. 冠心病心绞痛中医疗效评价标准[J]. 中国实验方剂学杂志, 2018, 24(15): 7-10.
    张秦风, 巩书文, 李虹, 等. 中叶素在糖尿病合并冠心病中的作用[J]. 中国动脉硬化杂志, 2018, 26(4): 424-428.
    郝清卿, 苑可心, 陈华, 等. 尼可地尔联合大剂量阿托伐他汀对冠心病合并糖尿病患者介入术后肾[J]. 中国糖尿病杂志, 2018, 26(5): 390-393.
    王森, 刘玲玲, 刘奕, 等. 尼可地尔联合前列地尔注射液治疗顽固性心绞痛的疗效分析[J]. 安徽医药, 2019, 23(4): 692-695.
    张丹丹, 刘欢, 陈嘉音, 等. 复方丹参滴丸与硝酸异山梨酯、单硝酸异山梨酯治疗冠心病心绞痛有效性和安全性的贝叶斯网状Meta分析[J]. 中国药物警戒, 2018, 15(7): 419-428.
    张德龙, 殷莉, 姜芳, 等. 丹参川芎嗪注射液联合单硝酸异山梨酯对冠心病不稳定型心绞痛血脂水平及疗效的影响[J]. 中华中医药学刊, 2019, 37(6): 1451-1454.
    马莹慧, 冯波, 朱鹤云, 等. 北五味子中总木脂素类成分的抗氧化及抗炎活性研究[J]. 食品研究与开发, 2019, 40(11): 25-30.
    吉其舰, 孙兆瑞, 杨志洲, 等. 人参皂苷Rg1对LPS诱导的肺上皮细胞凋亡和自噬的影响[J]. 中国中药杂志, 2019, 44(8): 1648-1653.
    王莹, 王华, 赵丽, 等. 麦冬多糖的提取工艺优化及其抗氧化活性分析[J]. 食品研究与开发, 2019, 40(19): 82-87.
    熊萱, 张远, 喻冬柯, 等. 中国冠心病患者ApoE基因型和高敏C反应蛋白临床相关性研究[J]. 四川医学, 2019, 40(6): 549-552.
    李镇, 邵名亮, 胡龙, 等. 血清同型半胱氨酸及载脂蛋白A-Ⅰ水平与冠心病的关联分析[J]. 安徽医药, 2019, 23(8): 1543-1546.

Catalog

    Article views (424) PDF downloads (15) Cited by()

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return